1. new squeeze plays #stocks http://www.chartmill.com/stockscreener.php?filters=sqds%2Cv1_50b300%2Cp_pg5%2Cti_105&tab=5&p=0&v=3&s=0&ticker=&nt=&timeframe=DAILY&type=CANDLES&o1=0&op1=14&i1=58&ip1=10&cl=F&months=0&o2=57&op2=20%2C1.5%2C10&i2=&ip2=&width=800&o3=1&op3=&i3=&ip3= $CVTI $XON $MDVN

  2. $MDVN Assets are Growing. Here s the Chart: http://lite.capitalmarketlabs.com/cmld3b/index.php?shortcode=MDVN&financial_bar=Assets+(US$+Millions)&financial_line=Assets+(US$+Millions)&start_date=12/31/2004&end_date=12/31/2014&show_line=false&sk=9c3ed523eab67d1526a0bd6d46aebd35

  3. @ChartMill: today s squeeze plays http://www.chartmill.com/stockscreener.php?filters=sqds%2Cv1_50b300%2Cp_pg5%2Cti_105&tab=5&p=0&v=3&s=0&ticker=&nt=&timeframe=DAILY&type=CANDLES&o1=0&op1=14&i1=58&ip1=10&cl=F&months=0&o2=57&op2=20%2C1.5%2C10&i2=&ip2=&width=800&o3=1&op3=&i3=&ip3= #stocks $CVTI $XON $MDVN squeeze as in Bollinger Band Squeeze? Not Short Squeeze

  4. today s squeeze plays http://www.chartmill.com/stockscreener.php?filters=sqds%2Cv1_50b300%2Cp_pg5%2Cti_105&tab=5&p=0&v=3&s=0&ticker=&nt=&timeframe=DAILY&type=CANDLES&o1=0&op1=14&i1=58&ip1=10&cl=F&months=0&o2=57&op2=20%2C1.5%2C10&i2=&ip2=&width=800&o3=1&op3=&i3=&ip3= #stocks $CVTI $XON $MDVN

  5. #stocks squeeze play setups http://www.chartmill.com/stockscreener.php?filters=sqds%2Cv1_50b300%2Cp_pg5%2Cti_105&tab=5&p=0&v=3&s=0&ticker=&nt=&timeframe=DAILY&type=CANDLES&o1=0&op1=14&i1=58&ip1=10&cl=F&months=0&o2=57&op2=20%2C1.5%2C10&i2=&ip2=&width=800&o3=1&op3=&i3=&ip3= $CVTI $XON $MDVN

  6. new squeeze plays #stocks http://www.chartmill.com/stockscreener.php?filters=sqds%2Cv1_50b300%2Cp_pg5%2Cti_105&tab=5&p=0&v=3&s=0&ticker=&nt=&timeframe=DAILY&type=CANDLES&o1=0&op1=14&i1=58&ip1=10&cl=F&months=0&o2=57&op2=20%2C1.5%2C10&i2=&ip2=&width=800&o3=1&op3=&i3=&ip3= $MDVN $ZAGG $APAM

  7. #stocks squeeze play setups http://www.chartmill.com/stockscreener.php?filters=sqds%2Cv1_50b300%2Cp_pg5%2Cti_105&tab=5&p=0&v=3&s=0&ticker=&nt=&timeframe=DAILY&type=CANDLES&o1=0&op1=14&i1=58&ip1=10&cl=F&months=0&o2=57&op2=20%2C1.5%2C10&i2=&ip2=&width=800&o3=1&op3=&i3=&ip3= $MDVN $ZAGG $APAM

  8. #stocks http://www.chartmill.com/stockscreener.php?filters=sqds%2Cv1_50b300%2Cp_pg5%2Cti_105&tab=5&p=0&v=3&s=0&ticker=&nt=&timeframe=DAILY&type=CANDLES&o1=0&op1=14&i1=58&ip1=10&cl=F&months=0&o2=57&op2=20%2C1.5%2C10&i2=&ip2=&width=800&o3=1&op3=&i3=&ip3= squeeze plays on $MDVN $ZAGG $APAM

  9. new squeeze plays #stocks http://www.chartmill.com/stockscreener.php?filters=sqds%2Cv1_50b300%2Cp_pg5%2Cti_105&tab=5&p=0&v=3&s=0&ticker=&nt=&timeframe=DAILY&type=CANDLES&o1=0&op1=14&i1=58&ip1=10&cl=F&months=0&o2=57&op2=20%2C1.5%2C10&i2=&ip2=&width=800&o3=1&op3=&i3=&ip3= $MDVN $ZAGG $APAM

  10. #stocks squeeze play setups http://www.chartmill.com/stockscreener.php?filters=sqds%2Cv1_50b300%2Cp_pg5%2Cti_105&tab=5&p=0&v=3&s=0&ticker=&nt=&timeframe=DAILY&type=CANDLES&o1=0&op1=14&i1=58&ip1=10&cl=F&months=0&o2=57&op2=20%2C1.5%2C10&i2=&ip2=&width=800&o3=1&op3=&i3=&ip3= $MDVN $ZAGG $APAM

  11. $MDVN: Medivation Announces First Quarter 2015 Financial Results ... http://stocknewshour.com/medivation-announces-first-quarter-2015-financial-results

  12. Shares of Medivation Bruised Slightly Proceeding A News Story (NASDAQ: $MDVN) #MDVN

  13. $MDVN Oh look, yet another strong recovery. Movin along.

  14. Analytic Investment holds an allocation of 1.3% in $MDVN in his Focus Growth Investment Portfolio

  15. $INCY vs. $ALKS vs. $MDVN vs. $PCYC Compared Across 9 Critical Measures http://lite.capitalmarketlabs.com/cmld3b/tt.php?tickers=INCY|ALKS|MDVN|PCYC|&metrics=Revenue+(TTM+US$+Millions)|Net+Income+(TTM+US$+Millions)|Revenue/Number+of+Employees+(TTM+US$+Millions)|Gross+Margin+%|Net+Income+Margin+%|Research+and+Development+Expense/Operating+Expense|Revenue+TTM,+1-Year+Growth+%|Net+Income+TTM,+1-Year+Growth+%|Price+to+Sales+(at+Quarter+End)

  16. @OphirGottlieb $MDVN vs. $ISIS vs. $UTHR vs. $OPK Compared Across 9 Critical Measures http://lite.capitalmarketlabs.com/cmld3b/tt.php?tickers=MDVN|ISIS|UTHR|OPK|&metrics=Revenue+(TTM+US$+Millions)|Net+Income+(TTM+US$+Millions)|Revenue/Number+of+Employees+(TTM+US$+Millions)|Gross+Margin+%|Net+Income+Margin+%|Research+and+Development+Expense/Operating+Expense|Revenue+TTM,+1-Year+Growth+%|Net+Income+TTM,+1-Year+Growth+%|Price+to+Sales+(at+Quarter+End)

  17. $MDVN vs. $ISIS vs. $UTHR vs. $OPK Compared Across 9 Critical Measures http://lite.capitalmarketlabs.com/cmld3b/tt.php?tickers=MDVN|ISIS|UTHR|OPK|&metrics=Revenue+(TTM+US$+Millions)|Net+Income+(TTM+US$+Millions)|Revenue/Number+of+Employees+(TTM+US$+Millions)|Gross+Margin+%|Net+Income+Margin+%|Research+and+Development+Expense/Operating+Expense|Revenue+TTM,+1-Year+Growth+%|Net+Income+TTM,+1-Year+Growth+%|Price+to+Sales+(at+Quarter+End)

  18. $BMRN vs. $PCYC vs. $VRTX vs. $MDVN Compared Across 9 Critical Measures http://lite.capitalmarketlabs.com/cmld3b/tt.php?tickers=BMRN|PCYC|VRTX|MDVN|&metrics=Revenue+(TTM+US$+Millions)|Net+Income+(TTM+US$+Millions)|Revenue/Number+of+Employees+(TTM+US$+Millions)|Gross+Margin+%|Net+Income+Margin+%|Research+and+Development+Expense/Operating+Expense|Revenue+TTM,+1-Year+Growth+%|Net+Income+TTM,+1-Year+Growth+%|Price+to+Sales+(at+Quarter+End)

  19. $BMRN $ALXN $AGIO $ISIS $MDVN Instant 9 Variable Company Comparison >> http://lite.capitalmarketlabs.com/cmld3b/tt.php?tickers=BMRN%7CALXN%7CAGIO%7CISIS%7CMDVN&metrics=Revenue%20(TTM%20US%24%20Millions)%7CNet%20Income%20(TTM%20US%24%20Millions)%7CRevenue%2FNumber%20of%20Employees%20(TTM%20US%24%20Millions)%7CGross%20Margin%20%25%7CNet%20Income%20Margin%20%25%7CResearch%20and%20Development%20Expense%2FOperating%20Expense%7CRevenue%20TTM%2C%201-Year%20Growth%20%25%7CNet%20Income%20TTM%2C%201-Year%20Growth%20%25%7CPrice%20to%20Sales%20(at%20Quarter%20End)%7CNon-Performing%20Loans%2FLoans%7COperating%20Revenues%2FOperating%20Expense via @CapitalMarketLabs

  20. $MDVN, $XRCA, $KATE, $INFN, $ENPH, $TOL, $TMHC High-growth stocks of interest >> daily finviz charts >> http://finviz.com/screener.ashx?v=211&ta=0&o=-change&t=,MDVN,XRCA,KATE,INFN,ENPH,TOL,TMHC

  21. $INCY vs. $BMRN vs. $MDVN vs. $ISIS Compared Across 9 Critical Measures http://lite.capitalmarketlabs.com/cmld3b/tt.php?tickers=INCY|BMRN|MDVN|ISIS|&metrics=Revenue+(TTM+US$+Millions)|Net+Income+(TTM+US$+Millions)|Revenue/Number+of+Employees+(TTM+US$+Millions)|Gross+Margin+%|Net+Income+Margin+%|Research+and+Development+Expense/Operating+Expense|Revenue+TTM,+1-Year+Growth+%|Net+Income+TTM,+1-Year+Growth+%|Price+to+Sales+(at+Quarter+End)

  22. $ALKS vs. $UTHR vs. $ISIS vs. $MDVN Compared Across 9 Critical Measures http://lite.capitalmarketlabs.com/cmld3b/tt.php?tickers=ALKS|UTHR|ISIS|MDVN|&metrics=Revenue+(TTM+US$+Millions)|Net+Income+(TTM+US$+Millions)|Revenue/Number+of+Employees+(TTM+US$+Millions)|Gross+Margin+%|Net+Income+Margin+%|Research+and+Development+Expense/Operating+Expense|Revenue+TTM,+1-Year+Growth+%|Net+Income+TTM,+1-Year+Growth+%|Price+to+Sales+(at+Quarter+End)

  23. $MDVN 123 does not hold we will see 117

  24. $MDVN will test 50dy moving avg 123.00

  25. $INCY vs. $MDVN vs. $ALKS vs. $ISIS Compared Across 9 Critical Measures http://lite.capitalmarketlabs.com/cmld3b/tt.php?tickers=INCY|MDVN|ALKS|ISIS|&metrics=Revenue+(TTM+US$+Millions)|Net+Income+(TTM+US$+Millions)|Revenue/Number+of+Employees+(TTM+US$+Millions)|Gross+Margin+%|Net+Income+Margin+%|Research+and+Development+Expense/Operating+Expense|Revenue+TTM,+1-Year+Growth+%|Net+Income+TTM,+1-Year+Growth+%|Price+to+Sales+(at+Quarter+End)